145 related articles for article (PubMed ID: 37658133)
21. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori.
Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM
J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anti-Helicobacter pylori activity of pyloricidin derivatives II. The combination of amino acid residues in the dipeptidic moiety and its effect on the anti-Helicobacter pylori activity.
Hasuoka A; Nishikimi Y; Nakayama Y; Kamiyama K; Nakao M; Miyagawa K; Nishimura O; Fujino M
J Antibiot (Tokyo); 2002 May; 55(5):499-507. PubMed ID: 12139019
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial activities of oxyprenylated chalcones and napthtoquinone against Helicobacter pylori.
Bodet C; Burucoa C; Rouillon S; Bellin N; Taddeo VA; Fiorito S; Genovese S; Epifano F
Nat Prod Commun; 2014 Sep; 9(9):1299-301. PubMed ID: 25918797
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (S.Y.Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori.
Rong Q; Xu M; Dong Q; Zhang Y; Li Y; Ye G; Zhao L
BMC Complement Altern Med; 2016 Aug; 16(1):331. PubMed ID: 27576439
[TBL] [Abstract][Full Text] [Related]
25. Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus.
Liu JH; Li L; Shang XD; Zhang JL; Tan Q
J Ethnopharmacol; 2016 May; 183():54-58. PubMed ID: 26364939
[TBL] [Abstract][Full Text] [Related]
26. Anti-Helicobacter pylori Activity of Isocoumarin Paepalantine: Morphological and Molecular Docking Analysis.
Damasceno JPL; Rodrigues RP; Gonçalves RCR; Kitagawa RR
Molecules; 2017 May; 22(5):. PubMed ID: 28498343
[TBL] [Abstract][Full Text] [Related]
27. Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives.
Yoshida Y; Barrett D; Azami H; Morinaga C; Matsumoto S; Matsumoto Y; Takasugi H
Bioorg Med Chem; 1999 Nov; 7(11):2647-66. PubMed ID: 10632076
[TBL] [Abstract][Full Text] [Related]
28. Benzimidazole derivatives: A versatile scaffold for drug development against Helicobacter pylori-related diseases.
Rostami H; Haddadi MH
Fundam Clin Pharmacol; 2022 Dec; 36(6):930-943. PubMed ID: 35716372
[TBL] [Abstract][Full Text] [Related]
29. Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials.
Ohishi T; Inaoka DK; Kita K; Kawada M
Chem Pharm Bull (Tokyo); 2018; 66(3):239-242. PubMed ID: 29491257
[TBL] [Abstract][Full Text] [Related]
30.
Chung JW; Kim SY; Park HJ; Chung CS; Lee HW; Lee SM; Kim I; Pak JH; Lee GH; Jeong JY
Gut Liver; 2017 Sep; 11(5):648-654. PubMed ID: 28750485
[TBL] [Abstract][Full Text] [Related]
31. Anti-Helicobacter pylori activity of Plumbago zeylanica L.
Wang YC; Huang TL
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):407-12. PubMed ID: 15708315
[TBL] [Abstract][Full Text] [Related]
32.
Xu YF; Lian DW; Chen YQ; Cai YF; Zheng YF; Fan PL; Ren WK; Fu LJ; Li YC; Xie JH; Cao HY; Tan B; Su ZR; Huang P
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320722
[TBL] [Abstract][Full Text] [Related]
33. Influence of adding vitamin D3 to standard clarithromycin-based triple therapy on the eradication rates of Helicobacter pylori infection.
El Shahawy MS; Shady ZM; Gaafar A
Arab J Gastroenterol; 2021 Sep; 22(3):209-214. PubMed ID: 34521593
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
[TBL] [Abstract][Full Text] [Related]
36. The antibacterial effect of fatty acids on Helicobacter pylori infection.
Jung SW; Lee SW
Korean J Intern Med; 2016 Jan; 31(1):30-5. PubMed ID: 26767854
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of Aloe vera inner gel against Helicobacter pylori strains.
Cellini L; Di Bartolomeo S; Di Campli E; Genovese S; Locatelli M; Di Giulio M
Lett Appl Microbiol; 2014 Jul; 59(1):43-8. PubMed ID: 24597562
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice.
De R; Sarkar A; Ghosh P; Ganguly M; Karmakar BC; Saha DR; Halder A; Chowdhury A; Mukhopadhyay AK
J Antimicrob Chemother; 2018 Jun; 73(6):1595-1603. PubMed ID: 29566160
[TBL] [Abstract][Full Text] [Related]
39. In silico design and in vitro assessment of anti-Helicobacter pylori compounds as potential small-molecule arginase inhibitors.
Fiori-Duarte AT; de Oliveira Guarnieri JP; de Oliveira Borlot JRP; Lancellotti M; Rodrigues RP; Kitagawa RR; Kawano DF
Mol Divers; 2022 Dec; 26(6):3365-3378. PubMed ID: 34997872
[TBL] [Abstract][Full Text] [Related]
40. Double liposomes mediated dual drug targeting for treatment of Helicobacter pylori infections.
Singh DY; Prasad NK
Pharmazie; 2011 May; 66(5):368-73. PubMed ID: 21699071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
